Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Key value for chemical safety assessment

Genetic toxicity in vitro

Description of key information

The genetic toxicity study was carried out according to OECD guideline 471 (Salmonella/Mammalian-Microsome Plate Incorporation Mutagenicity Assay (Ames test) with a confirmatory assay) is negative in the presence and in the absence of metabolic activation.

Endpoint Conclusion: No adverse effect observed (negative)

Link to relevant study records
Reference
Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2008-10-31 to 2008-11-21
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay
Target gene:
Reversion to histidine independence in Salmonella typhimurium and reversion to tryptophan independence in Escherichia coli.
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli, other: WP2 uvrA-
Metabolic activation:
with and without
Metabolic activation system:
Rat liver homogenate (10% liver S9 in standard cofactors)
Test concentrations with justification for top dose:
A preliminary test was carried out to determine the toxicity of the test material, where 10 concentrations (0 - 5000 ug/plate) and a vehicle control were tested. For experiment 1, five concentrations of the test material (50, 150, 500, 1500 and 5000 ug/plate) were assayed in triplicate against each tester strain, using the direct plate incorporation method. A second experiment was performed using the same methodology and the test material dose range for experiment 1.
Vehicle / solvent:
50 mg/ml Dimethyl formamide.
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
Remarks:
dimethyl formamide
True negative controls:
no
Positive controls:
yes
Remarks:
N-ethyl-N'-nitro-N-nitrosoguaniding (ENNG), 9-Aminoacridine (9AA), 4-Nitroquinoline-1-oxide (4NQO), 2-Aminoanthracene (2AA) and Benzo(a)pyrene (BP)
Evaluation criteria:
The assay may be considered valid if the following criteria are met:
All tester strain cultures exhibit a characteristic number of spontaneous revertants per plate in the vehicle and untreated controls.
The appropriate characteristics for each tester strain have been confirmed and all tester strain cultures should be in the range of 1 to 9.9 E+09 bacteria per ml.
Each mean positive control value should be at least twice the respective vehicle control value for each strain, thus demonstrating both the intrinsic sensitivity of the tester strains to mutagenic exposure and the integrity of the S9-mix.
There should be a minimum of 4 non-toxic test material dose levels and there should be no evidence of excessive contamination.
Statistics:
Statistical methods as recommended by the UKEMS.
Key result
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Remarks:
A globular precipitate was observed at 5000 ug/plate
Vehicle controls validity:
valid
Untreated negative controls validity:
other: Historical data from 2006-2007
Positive controls validity:
valid

The vehicle control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of the revertant colonies, both with or without metabolic activation. Thus the sensitivity of the assay and the efficacy of the S9-mix were validated.

Table 1 - Test Results: Experiment 1- Without metabolic activation

Test Period

From 10 November 2008 to 13 November 2008

Without S9-Mix

Test Substance concentration (µg/plate)

Number of revertants (mean number of colonies per plate)

Base pair substitution type

Frameshift type

TA100

TA1535

WP2uvrA-

TA98

TA1537

-

0

90

 

35

 

28

 

13

 

6

 

90 

(88)

32

(32)

17

(25)

12

(14)

6

(7)

83

4.0#

28

3.5

30

7.0

16

2.1

8

1.2

-

50

93

 

19

 

14

 

9

 

5

 

88

(83)

28

(24)

26

(20)

18

(16)

5

(5)

67

13.8

25

4.6

20

6.0

20

5.9

6

0.6

-

150

89

 

27

 

15

 

17

 

3

 

84

(82)

29

(26)

28

(21)

16

(16)

5

(3)

73

8.2

21

4.2

20

6.6

15

1.0

2

1.5

-

500

73

 

25

 

18

 

13

 

6

 

95

(84)

18

(21)

21

(18)

13

(14)

2

(3)

84

11.0

20

3.6

14

3.5

15

1.2

2

2.3

-

1500

89

 

24

 

17

 

17

 

5

 

80

(84)

20

(23)

17

(19)

21

(17)

2

(3)

83

4.6

24

2.3

24

4.0

13

4.0

3

1.5

-

5000

79 P

 

16 P

 

8 P

 

12 P

 

4 P

 

67 P

(76)

15 P

(14)

14 P

(13)

10 P

(11)

3 P

(4)

83 P

8.3

10 P

3.2

18 P

5.0

11 P

1.0

5 P

1.0

Positive controls S9-Mix

-

Name concentration (µg/plate) No. colonies per plate

ENNG

ENNG

ENNG

4NPQ

9AA

3

5

2

0.2

80

336

 

89

 

182

 

108

 

1425

 

405

(362)

111

(103)

197

(182)

114

(109)

812

(975)

346

37.3

109

12.2

167

15.0

105

4.6

687

395.0

P = precipitate, # = Standard deviation

Table 2 - Test Results: Experiment 1- With metabolic activation

Test Period

From 10 November 2008 to 13 November 2008

With S9-Mix

Test Substance concentration (µg/plate)

Number of revertants (mean number of colonies per plate)

Base pair substitution type

Frameshift type

TA100

TA1535

WP2uvrA-

TA98

TA1537

-

0

85

 

22

 

16

 

10

 

5

 

87 

(87)

26

(22)

22

(21)

14

(13)

5

(5)

90

2.5#

18

4.0

24

4.2

15

2.6

5

0.0

-

50

90

 

32

 

20

 

11

 

7

 

88

(86)

26

(27)

16

(19)

12

(11)

6

(5)

79

5.9

24

4.2

20

2.3

11

0.6

2

2.6

-

150

82

 

25

 

9

 

9

 

3

 

90

(89)

12

(19)

16

(15)

8

(8)

3

(3)

95

6.6

21

6.7

20

5.6

9

0.6

4

0.6

-

500

91

 

16

 

12

 

15

 

3

 

78

(80)

13

(16)

16

(16)

9

(11)

4

(4)

72

9.7

19

3.0

19

3.5

9

3.5

4

0.6

-

1500

86

 

19

 

15

 

12

 

4

 

75

(78)

17

(16)

18

(17)

10

(10)

2

(3)

73

7.0

13

3.1

17

1.5

9

1.5

4

1.2

-

5000

81 P

 

12 P

 

15 P

 

17 P

 

3 P

 

81 P

(79)

26 P

(18)

14 P

(14)

17 P

(17)

3 P

(4)

74 P

4.0

16 P

7.2

14 P

0.6

17 P

0.0

5 P

1.2

Positive controls S9-Mix

+

Name concentration (µg/plate) No. colonies per plate

2AA

2AA

2AA

BP

2AA

1

2

10

5

2

389

 

215

 

269

 

208

 

132

 

461

(428)

244

(428)

276

(237)

196

(215)

176

(175)

433

36.3

252

19.5

272

3.5

240

22.7

217

42.5

 

Conclusions:
Interpretation of results: negative with and without metabolic activation

No evidence of mutagenicity was seen under the conditions of this assay. The test material is considered to be non-mutagenic
Executive summary:

The mutagenicity of Hydrolysed reaction products of furan-2,5-dione and C15-18-(linear and branched)-alkenes was investigated in an Ames test (plate incorporation assay) using S. typhimurium strains TA98, TA100, TA1535 and TA1537 and Escherichia coli WP2uvrA-. Three replicate plates of each strain were exposed to the test material at concentrations of 50, 150, 500, 1500 and 5000 ug/plate in the presence and absence of an exogenous metabolic activation system (Rat liver homogenate (10% liver S9 in standard cofactors)). There was no evidence of cytotoxicity at the limit concentration; globular precipitation of the test material was seen at 5000 ug/plate. Exposure to the test material did not induce increased numbers of revertant colonies of any strain. Appropriate positive control compounds induced large increases in the numbers of revertant colonies, confirming the sensitivity of the assay. Results were confirmed in an independently-repeated assay. No evidence of mutagenicity was seen under the conditions of this study.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (negative)

Additional information

The mutagenicity test ((Bowles, A.J., 2009) of Hydrolysed reaction products of furan-2,5-dione and C15-18-(linear and branched)-alkenes was investigated in an Ames test (plate incorporation assay) using S. typhimurium strains TA98, TA100, TA1535 and TA1537 and Escherichia coli WP2uvrA-. Three replicate plates of each strain were exposed to the test material at concentrations of 50, 150, 500, 1500 and 5000 ug/plate in the presence and absence of an exogenous metabolic activation system. There was no evidence of cytotoxicity at the limit concentration; globular precipitation of the test material was seen at 5000 ug/plate. Exposure to the test material did not induce increased numbers of revertant colonies of any strain. Appropriate positive control compounds induced large increases in the numbers of revertant colonies, confirming the sensitivity of the assay. Results were confirmed in an independently-repeated assay. No evidence of mutagenicity was seen under the conditions of this study.

Justification for classification or non-classification

Based on the limited data available, Hydrolysed reaction products of furan-2,5-dione and C15-18-(linear and branched)-alkenes is not considered to be mutagenic according to Regulation (EC) No 1272/2008.